- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/62 - DNA sequences coding for fusion proteins
Patent holdings for IPC class C12N 15/62
Total number of patents in this class: 10545
10-year publication summary
|
458
|
541
|
851
|
788
|
856
|
1010
|
1035
|
872
|
899
|
425
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20611 |
151 |
| The Trustees of the University of Pennsylvania | 4405 |
92 |
| President and Fellows of Harvard College | 6065 |
77 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
74 |
| The Board of Trustees of the Leland Stanford Junior University | 6621 |
63 |
| The Broad Institute, Inc. | 1952 |
61 |
| The General Hospital Corporation | 4845 |
57 |
| Regeneron Pharmaceuticals, Inc. | 4647 |
57 |
| Sangamo Therapeutics, Inc. | 386 |
45 |
| Centre National de La Recherche Scientifique | 10922 |
42 |
| Massachusetts Institute of Technology | 10210 |
40 |
| National Research Council of Canada | 1543 |
39 |
| Novartis AG | 10336 |
38 |
| F. Hoffmann-La Roche AG | 7843 |
37 |
| Board of Regents, The University of Texas System | 6070 |
37 |
| The Johns Hopkins University | 5849 |
37 |
| JCR Pharmaceuticals Co., Ltd. | 228 |
36 |
| Monsanto Technology LLC | 8197 |
34 |
| Cue Biopharma, Inc. | 201 |
33 |
| University Health Network | 1063 |
32 |
| Other owners | 9463 |